follow @ClinPsychNews
RSS Feeds
Find Us on Facebook

Patients Substitute Marijuana for Prescription Drugs

By: M. ALEXANDER OTTO, Clinical Psychiatry News Digital Network

10/31/11

FROM THE AMERICAN PSYCHIATRIC ASSOCIATION'S INSTITUTE ON PSYCHIATRIC SERVICES

Bookmark and Share



Vitals

Major Finding: In an anonymous survey, 66% of respondents said that they use marijuana as a prescription-drug substitute.

Data Source: Survey of 350 medical marijuana clients at the Berkeley Patients Group, a medical marijuana dispensary in Berkeley, Calif.

Disclosures: Dr. Reiman said she has no financial conflicts.

SAN FRANCISCO – People who qualify for medical marijuana prescriptions frequently report substituting the substance for their other prescription medications.

In an anonymous survey, 66% of 350 clients at the Berkeley (Calif.) Patients Group, a medical marijuana dispensary, said that they use marijuana as a prescription drug substitute. Their reasons: Cannabis offered better symptom control with fewer side effects than did prescription drugs.

©ron hilton/iStockphoto.com


Two-thirds of a medical marijuana dispensary’s surveyed clients admitted to using cannabis as a substitute for prescription drugs.

 

Those with pain symptoms said that marijuana has less addiction potential than do opioids. Others said marijuana helped to reduce the dose of other medications.

"Instead of having a pain medication, an antianxiety medication, and a sleep medication, they are able to just use cannabis, and that controls all of those symptoms," said Amanda Reiman, Ph.D., the director of research and social services at the Berkeley center. Almost 50% of those surveyed said they use cannabis two or three times per day.

More than 75% of respondents said they used cannabis for psychiatric disorders, including bipolar disorder, posttraumatic stress disorder, depression, anxiety, and persistent insomnia. Unlike some psychiatric drugs, they said, marijuana didn’t leave them feeling like "zombies," Dr. Reiman reported at the American Psychiatric Association’s Institute on Psychiatric Services.

Almost 70% of those surveyed were men and about 66% were white, in line with the center’s overall demographics. Respondents’ mean age was about 40 years, and ranged from 18 to 81 years. About two-thirds were employed; 81% had at least some college; and 28% made more than $60,000/year. More than half were single.

About 75% had health insurance that covered prescriptions. Even so, "they are still opting to utilize medical cannabis, which is not covered by insurance," Dr. Reiman said.

About 70% said they had a chronic condition, such as diabetes or arthritis. Just over half said they used marijuana for pain relief, including arthritis, migraines, and accident-related injuries. Other uses included appetite stimulation and relief of symptoms from carpal tunnel syndrome and multiple sclerosis.

"Instead of having a pain medication, an antianxiety medication, and a sleep medication, they are able to just use cannabis."

The amounts used – typically 3-8 g per week – were fairly stable with about 70% reporting no change in marijuana use in the past 6 months. Most "experience a stable level of use throughout their entire course of treatment," Dr. Reiman said.

In operation for 12 years, the Berkeley Patients Group has more than 6,000 patients who pay $15-$60 for one-eighth of an ounce of marijuana – 3.5 grams – depending on strain and potency.

To buy, patients must have a letter from their doctor recommending marijuana for a medical condition. Center staff verifies the letter with a call to the physician. The center obtains the marijuana from its own patients – a must under California law – who grow it and sell it to the dispensary.

Besides smokable marijuana, BPG offers cannabis-laced edibles, capsules, and extract drops to put under the tongue or in tea or coffee, as well as topical marijuana cream for pain and inflammation relief, Dr. Reiman said.

I would like to receive Clinical Psychiatry News E-Newsletter The Cognoscenti each week.


Specialty Focus
Sponsored by


calendar
May 24 - 27
Chicago, IL
Association for Psychological Science (APS): Annual Convention
May 29 - Jun 1
Phoenix, AZ
National Institute of Mental Health (NIMH): New Clinical Drug Evaluation Unit (NCDEU)
Jun 3 - 7
Stockholm,
Collegium Internationale Neuro-Psychopharmacologicum (CINP): World Congress
Jun 5 - 10
Kona, HI
International Behavioral Neuroscience Society (IBNS): Annual Meeting
Jun 12 - 17
Chicago, IL
American Psychoanalytic Association (APsaA): 101st Annual Meeting
Jun 18 - 26
Rapid City, SD
Reclaiming Youth International: 19th Annual Black Hills Seminars
Jun 23 - 27
San Francisco, CA
Research Society on Alcoholism (RSA): Annual Scientific Conference
Jul 10 - 13
Liverpool,
Royal College of Psychiatrists: Annual Meeting
Jul 21 - 28
Dpart Venice,
Primary Care: Mental Health Issues with a Focus on Drugs and Behavior
Jul 21 - 25
Paris,
International Association for Child & Adolescent Psych & Allied Professions (IACAPAP): World Congress
More Calendar »